Clinicopathologic features of viral agents of potential use by bioterrorists

Clinics in Laboratory Medicine

Volumn 21, Issue 3, 2001, Pages 475-493

  Burgess, T H ^a   Steele, K E ^a   Schoneboom, B A ^a   Grieder, F B ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CIDOFOVIR; MACROGOL; RIBAVIRIN;

ALPHA VIRUS; ARENAVIRUS; BIOLOGICAL WARFARE; CLINICAL FEATURE; DESTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE MODEL; DRUG EFFICACY; EBOLA VIRUS; ENCEPHALOMYELITIS; FLAVIVIRUS; HUMAN; IMMUNE RESPONSE; LASSA FEVER; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; REVIEW; RIFT VALLEY FEVER BUNYAVIRUS; SMALLPOX; SYMPTOM; VIRUS HEMORRHAGIC FEVER; VIRUS IMMUNITY; VIRUS INFECTION; YELLOW FEVER;

EID: 0034828824     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30019-2     Document Type: Review

References (106)

1. Management of a Sabia virus-infected patient in a US hospital
2. The West Nile virus outbreak of 1999 in New York: The flushing hospital experience
3. Clinical aspects of human Venezuelan equine encephalitis in Texas
4. Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection
5. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge
6. Argentine hemorrhagic fever in pregnant women
7. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients
8. Identification of a new Venezuelan equine encephalitis virus from Brazil
9. Surveillance for West Nile virus in overwintering mosquitoes-New York 2000
10. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse
11. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology
12. The pathologic anatomy and histology of variola
13. Pathology of experimental Ebola virus infection in African green monkeys: Involvement of fibroblastic reticular cells
14. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
15. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone
16. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant
17. Venezuelan hemorrhagic fever: Clinical and epidemiological studies of 165 cases
18. Serologic evidence for an epizootic dengue virus infecting toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka
19. Ebola virus infection in imported primates-Virginia, 1989
20. Current status of the treatment of Argentine hemorrhagic fever
21. Anfiviral Antiviral treatment of Argentine hemorrhagic fever
22. Poxviruses
23. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-alpha
24. Commentary: Smallpox eradication in west and central Africa revisited
25. Clinical features of Lassa fever in Liberia
26. Vaccinia necrosum and its relationship to impaired immunologic responsiveness
27. Hierarchies of antigen-specific cytotoxic T-cell responses
28. Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in the rat
29. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia
30. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus
31. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins
32. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages
33. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection
34. Imported Lassa fever in Germany: Molecular characterization of a new Lassa virus strain
35. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, liveattenuated V3526 vaccine candidate
36. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice
37. Bioterrorism as a public health threat
38. Smallpox: Clinical and epidemiologic features
39. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates
40. Re-emergence of monkeypox in Africa: A review of the past six years
41. Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: Enhanced primary immune response and altered pattern of antibody class elicited
42. West Nile fever: A reemerging mosquito-borne viral disease in Europe
43. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug
44. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory
45. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure
46. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters
47. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys
48. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus
49. Alphaviruses
50. Experimental smallpox in chimpanzees
51. Chemotherapy of respiratory viruses
52. The causative agent of infectious equine encephalomyelitis in Venezuela
53. Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus
54. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern U.S.
55. In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: The small 6,000-molecular-weight membrane protein modulates virus release
56. Pegylated alpha interferon is an effective treatment for virulent Venezuelan equine encephalitis virus and has profound effects on the host immune response to infection
57. Isolation of two strains of West Nile virus during an outbreak in southern Russia, 1999
58. Immune evasion by adenoviruses
59. A mouse model of aerosol-transmitted orthopoxviral disease: Morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system
60. Flaviviruses
61. The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus
62. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients: International Scientific and Technical Committee
63. Immunization against virus disease
64. Host metabolic alterations during Venezuelan equine encephalitis in the rat
65. Outbreak of Ebola viral hemorrhagic fever - Zaire, 1995
66. Outbreak of West Nile-like viral encephalitis - New York, 1999
67. Outbreak of Rift Valley fever - Saudi Arabia, August-October, 2000
68. Overview of hemorrhagic fevers
69. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator
70. Vee in Texas: An on-the-scene report (July 28, 1971)
71. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
72. The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants
73. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates
74. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
75. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
76. Glucan-induced enhancement of host resistance to selected infectious diseases
77. Production of infectious RNA transcripts from Sindbis virus cDNA clones: Mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants
78. Rift Valley fever - Egypt, 1993
79. Rift Valley Fever - East Africa, 1997-1998
80. Epidemiology of arthropod-borne encephalitis
81. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates
82. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice
83. Astrocytes as targets for Venezuelan equine encephalitis virus infection
84. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice
85. Study of the treatment-prophylactic effect of immunomodulators in experimental infections, caused by Marburg, Ebola, and Venezuelan equine encephalitis viruses
86. Smallpox in Birmingham
87. Viral encephalitides
88. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice
89. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York
90. Epidemic Venezuelan equine encephalitis in North America in 1971: Vector studies
91. Arboviral encephalitides
92. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients
93. Vaccines for mucosal immunity to combat emerging infectious diseases
94. Induction of protective immunity against Dengue virus type 2: Comparison of candidate live attenuated and recombinant vaccines
95. Markedly elevated levels of interferon-gamma, IFN-alpha, IL-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection
96. Venezuelan equine encephalitis in BALB/c mice: Kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation
97. The agents of biological warfare
98. Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region
99. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America
100. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe
101. Effect of ribavirin and immune serum on Junin virus-infected primates
102. The global eradication of smallpox
103. A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever